Skip to main content
HR 6531 116th Congress House Health Congressional oversight Emergency medical services and trauma care Health programs administration and funding Health technology, devices, supplies Immunology and vaccination Manufacturing Medical tests and diagnostic methods Prescription drugs Public contracts and procurement Strategic materials and reserves

Medical Supplies for Pandemics Act of 2020

Introduced: April 17, 2020 Introduced by: Dingell, Debbie Democratic · Michigan See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 17, 2020
Referred to the House Committee on Energy and Commerce.
Apr 17, 2020
Introduced in House
 Plain-English summary Congressional Research Service

Medical Supplies for Pandemics Act of 2020

This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies. Specifically, HHS must (1) create incentives for manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture.

The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2023.

What's happening now April 17, 2020

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1